---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-020262"
form_type: "8-K"
ticker: "INBS"
cik: "0001725430"
company_name: "INTELLIGENT BIO SOLUTIONS INC."
filed_at: "2025-10-30T23:59:59+00:00"
generated_at: "2026-05-17T01:23:05.977423+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# INBS adds 33 new customer accounts in Q1 FY2026, up 50% YoY; total active accounts exceed 480

## Summary
- Added 33 new customer accounts in fiscal Q1 ended Sept 30, 2025, a 50% increase YoY.
- Total active accounts reached over 480; growth driven by maritime, transport, logistics, and new government sector.
- 91% of new accounts were first-time adopters; 9% expanded use within existing organizations.
- Strong UK growth supported by distributor expansion across Europe and Middle East.
- Global drug screening market projected at $17.1B by 2029, 15% CAGR, supporting INBS's expansion.

## SEC filing metadata
- accession: 0001493152-25-020262
- form_type: 8-K
- ticker: INBS
- cik: 0001725430
- company_name: INTELLIGENT BIO SOLUTIONS INC.
- filed_at: 2025-10-30T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1725430/000149315225020262/0001493152-25-020262-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1725430/000149315225020262/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-020262
- JSON: https://secwatch.observer/filing/0001493152-25-020262.json
- Plain text: https://secwatch.observer/filing/0001493152-25-020262.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.